BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6306028)

  • 1. High-performance liquid chromatographic determination of cefmenoxime (AB-50912) in human plasma and urine.
    Noonan IA; Gambertoglio JG; Barriere SL; Conte JE; Lin ET
    J Chromatogr; 1983 Apr; 273(2):458-63. PubMed ID: 6306028
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid-chromatographic assay of cefmenoxime in serum and urine.
    Reitberg DP; Schentag JJ
    Clin Chem; 1983 Jul; 29(7):1415-8. PubMed ID: 6305536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.
    Borner K; Borner E; Lode H; Peters A
    Eur J Clin Microbiol; 1983 Feb; 2(1):17-21. PubMed ID: 6301809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cefotaxime, desacetylcefotaxime, cefmenoxime and ceftizoxime in biological samples by fluorescence detection after separation by thin-layer chromatography.
    Blanchin MD; Rondot-Dudragne ML; Fabre H; Mandrou B
    Analyst; 1988 Jun; 113(6):899-902. PubMed ID: 3218764
    [No Abstract]   [Full Text] [Related]  

  • 5. A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasma.
    Granneman GR; Sennello LT
    J Chromatogr; 1982 Apr; 229(1):149-57. PubMed ID: 6282912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micromethod for the determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography.
    Demotes-Mainard FM; Vinçon GA; Jarry CH; Albin HC
    J Chromatogr; 1984 Dec; 336(2):438-45. PubMed ID: 6099369
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
    Itakura K; Mitani M; Aoki I; Usui Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):622-7. PubMed ID: 6284390
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of ceftriaxone, a novel cephalosporin, in plasma, urine and saliva by high-performance liquid chromatography on an NH2 bonded-phase column.
    Ascalone V; Dal Bò L
    J Chromatogr; 1983 Apr; 273(2):357-66. PubMed ID: 6306026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assay of cefotaxime and desacetylcefotaxime in plasma and urine by high performance liquid chromatography].
    Demotes-Mainard F; Vinçon G; Bouchet JL; Jarry C; Albin H
    Ann Biol Clin (Paris); 1984; 42(4):301-5. PubMed ID: 6093635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
    Gambertoglio JG; Alexander DP; Barriere SL
    Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cefodizime in biological materials by high-performance liquid chromatography.
    Marunaka T; Matsushima E; Maniwa M
    J Chromatogr; 1987 Sep; 420(2):329-39. PubMed ID: 3693504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography.
    Falkowski AJ; Look ZM; Noguchi H; Silber BM
    J Chromatogr; 1987 Nov; 422():145-52. PubMed ID: 3437003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stability of cefixime (FK-027) in serum, urine and buffer.
    Knöller J; Schönfeld W; Bremm KD; König W
    J Chromatogr; 1987 Feb; 389(1):312-6. PubMed ID: 3571358
    [No Abstract]   [Full Text] [Related]  

  • 16. Penetration of cefmenoxime into cerebrospinal fluid of patients with bacterial meningitis.
    Humbert G; Veyssier P; Fourtillan JB; Bryskier A; Borsa F; Lallement PY; Bonmarchand G
    J Antimicrob Chemother; 1986 Oct; 18(4):503-6. PubMed ID: 3464585
    [No Abstract]   [Full Text] [Related]  

  • 17. [HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime].
    Pechinot A; Duez JM; Bryskier A; Labia R; Kazmierczak A
    Pathol Biol (Paris); 1984 May; 32(5):386-8. PubMed ID: 6330649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.
    Rolston KV; Chandrasekar PH; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1983 Nov; 12(5):519-21. PubMed ID: 6323372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed-phase high-performance liquid chromatographic method to determine ceftriaxone in biological fluids.
    Bowman DB; Aravind MK; Miceli JN; Kauffman RE
    J Chromatogr; 1984 Jul; 309(1):209-13. PubMed ID: 6090490
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography.
    Dell D; Chamberlain J; Coppin F
    J Chromatogr; 1981 Dec; 226(2):431-40. PubMed ID: 6274890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.